semaglutide for obesity 50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Semaglutide for obesity – how

For the millions suffering in silence from back pain, GLP-1 therapies offer not just symptom relief, but the possibility of a more active, less painful life

Promising results were also obtained by rare element doping (Lee et al

The financial incentives were enormous: GLP-1 medications generated billions annually, creating powerful motivation to increase prescriptions rather than conduct thorough safety investigations or provide complete risk disclosures

RPMI), hematocrit (0.4% vs

Activation of AKT suppresses apoptosis triggered via blockade of MDM2-p53 interactions but is reversible upon simultaneous inhibition of rictor/mTOR complex

300 mg/kg) in a twice-daily dosing regimen to animals with behavioral evidence of tinnitus, starting at 4 wks after noise exposure and continuing for 14 consecutive days